Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline | Zendy

Ambarish Pandey | Zendy; Kershaw V. Patel | Zendy; Wanpen Vongpatanasin | Zendy; Colby Ayers | Zendy; Jarett D. Berry | Zendy; Robert J. Mentz | Zendy; Michael J. Blaha | Zendy; John W. McEvoy | Zendy; Paul Muntner | Zendy; Muthiah Vaduganathan | Zendy; Adolfo Correa | Zendy; Javed Butler | Zendy; Daichi Shimbo | Zendy; Vijay Nambi | Zendy; Christopher R. deFilippi | Zendy; Stephen L. Seliger | Zendy; Christie M. Ballantyne | Zendy; Elizabeth Selvin | Zendy; James A. de Lemos | Zendy; Parag H. Joshi | Zendy

Open Access

Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline

Author(s) -

Ambarish Pandey,

Kershaw V. Patel,

Wanpen Vongpatanasin,

Colby Ayers,

Jarett D. Berry,

Robert J. Mentz,

Michael J. Blaha,

John W. McEvoy,

Paul Muntner,

Muthiah Vaduganathan,

Adolfo Correa,

Javed Butler,

Daichi Shimbo,

Vijay Nambi,

Christopher R. deFilippi,

Stephen L. Seliger,

Christie M. Ballantyne,

Elizabeth Selvin,

James A. de Lemos,

Parag H. Joshi

Publication year - 2019

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.119.043337

Subject(s) - medicine , blood pressure , guideline , cardiology , heart failure , biomarker , natriuretic peptide , cohort , troponin , myocardial infarction , pathology , biochemistry , chemistry

Risk for atherosclerotic cardiovascular disease was a novel consideration for antihypertensive medication initiation in the 2017 American College of Cardiology/American Heart Association Blood Pressure (BP) guideline. Whether biomarkers of chronic myocardial injury (high-sensitivity cardiac troponin T ≥6 ng/L] and stress (N-terminal pro-B-type natriuretic peptide [NT-proBNP] ≥100 pg/mL) can inform cardiovascular (CV) risk stratification and treatment decisions among adults with elevated BP and hypertension is unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research